EUVIMEDEUVIMED entdecken
Crossref

Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis

Sung Il Im iD, Su Hyun Bae, Soo Jin Kim, Bong Joon Kim, Jung Ho Heo, Tae Won Jang, Edward P Gerstenfeld

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Sung Il Im und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Cardiology, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Pyridones, Idiopathic Pulmonary Fibrosis, Antifibrotic Agents, Heart Rate. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrosis is an important substrate for atrial fibrillation (AF), especially in structural heart disease. A previous study reported that pirfenidone, an antifibrotic agent, reduced atrial and left ventricular fibrosis in an animal model.

Objective

The present research aims to evaluate the effects of pirfenidone on arrhythmic and clinical outcomes in patients with idiopathic pulmonary fibrosis (IPF).

Methods

Our database of patients diagnosed with IPF between 2008 and 2023 was used to obtain echocardiography, electrocardiography (ECG), and 24‐h Holter monitoring data. The study included all patients with IPF treated with or without pirfenidone. We compared arrhythmic events, including AF, atrial premature complexes, atrial tachycardia, and ventricular arrhythmias, as well as clinical outcomes based on pirfenidone use.

Results

Among 248 patients with IPF (74.0 ± 8.9 years), 106 (41.2%) received pirfenidone. No differences in the baseline characteristics were observed. During a median 36‐month follow‐up period, a lower incidence of arrhythmic events ( p = 0.001) and diastolic dysfunction ( p = 0.025) were observed in the pirfenidone group. Univariate analysis showed associations between arrhythmic events and hypertension, coronary artery disease, higher body weight, longer PR interval, QRS duration, and absence of pirfenidone use. In a multivariable analysis, higher body weight and absence of pirfenidone use were independent risk factors for arrhythmic events.

Conclusions

Pirfenidone use to treat IPF was associated with fewer arrhythmic events and less diastolic dysfunction compared to patients who did not use pirfenidone during long‐term follow‐up. Additionally, obesity is associated with a higher incidence of arrhythmic events in patients with IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesIdiopathic Pulmonary FibrosisAntifibrotic AgentsHeart RateArrhythmias, CardiacHumansFemaleMaleAgedTreatment OutcomeRisk FactorsTime FactorsAged, 80 and overRetrospective StudiesDatabases, FactualRisk AssessmentElectrocardiography, AmbulatoryMiddle Aged

Stichwörter der Autor:innen

atrial fibrillationatrial fibrosispirfenidone

Substanzen

pirfenidonePyridonesAntifibrotic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Cardiology, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
  • Department of Internal Medicine, Division of Pulmonology, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
  • Section of Cardiac Electrophysiology, University of California, San Francisco, California, USA.

ORCID-Profile: Sung Il Im

Zitieren

APA

Im, S. I., Bae, S. H., Kim, S. J., Kim, B. J., Heo, J. H., Jang, T. W., & Gerstenfeld, E. P. (2026). Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70269

Vancouver

Im SI, Bae SH, Kim SJ, Kim BJ, Heo JH, Jang TW, et al. Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70269

BibTeX
@article{Im2026,
  author = {Im, Sung Il and Bae, Su Hyun and Kim, Soo Jin and Kim, Bong Joon and Heo, Jung Ho and Jang, Tae Won and Gerstenfeld, Edward P},
  title = {Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70269}
}
Kostenlos starten →